Growth Equity

Starbucks cedes majority control in China to Boyu Capital in a bold pivot, aiming for 20,000 stores amid fierce competition from local rivals.

A major lab expansion in Massachusetts aims to slash preclinical timelines for the most promising new cancer treatments, including advanced radiotherapies.

With $10M from ATEL Ventures, Carbon Upcycling is set to commercialize its breakthrough tech, turning CO2 and industrial waste into green building materials.

With a key data readout looming for its chronic cough drug, Nocion adds a renowned dealmaker to its board, fueling speculation of a potential acquisition.

With key hires from Thoratec and Medtronic, CorWave signals an aggressive push to commercialize its revolutionary undulating membrane heart pump technology.

Tech advisor Crosslake lands a major new investment from Falfurrias and Leonard Green, signaling a strategic shift in private equity exit strategies.

With a new strategic investment from Viking Global Investors, Valstone is set to accelerate its acquisition spree and AI development in critical industries.

The digital infrastructure firm secured new funding for expansion, but a steep discount in its offering has rattled investors and sent its share price plunging.

With a $2B war chest and a key simulation acquisition, Shield AI is accelerating the race to deploy AI pilots, reshaping the future of global defense.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

After a standout debut at CES 2026, the emotionally intelligent robot OlloNi is heading to Kickstarter. Can it turn industry buzz into a new reality?

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

From high-stakes charity auctions to new terroir-driven releases, Weather Wines is crafting a blueprint for modern luxury brand success in Sonoma County.

Venture firm Sonder Capital closes its new fund with backing from Mayo Clinic and Sutter Health, aiming to revolutionize patient care with AI-powered robotics.

Artis BioSolutions is opening a new synthetic DNA facility in Boston, aiming to reduce supply chain risks and accelerate next-gen medicine development.

Private equity firm Southfield Capital has acquired a majority stake in Metric Search, aiming to dominate the high-stakes recruitment market for niche talent.

DMZ's summit channels $210,000 to women-led startups, signaling a strategic push into Canada’s critical AI, defence, and cybersecurity sectors.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

With a new CEO driven by a personal mission, Cylinder Health aims to scale its virtual care model in the booming, high-cost digestive health market.

A new partnership signals a major shift in the aesthetics market, blending private equity scale with a new focus on university-backed provider education.